Toth Financial Advisory’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$1K 753
2022
Q3
$1K Buy
+100
New +$1.24K ﹤0.01% 687
2021
Q1
Sell
-100
Closed -$1K 690
2020
Q4
$1K Hold
100
﹤0.01% 572
2020
Q3
$1K Hold
100
﹤0.01% 520
2020
Q2
$1K Hold
100
﹤0.01% 503
2020
Q1
$1K Hold
100
﹤0.01% 417
2019
Q4
$2K Hold
100
﹤0.01% 425
2019
Q3
$2K Buy
+100
New +$1.99K ﹤0.01% 409

Other funds holding GOSS

Toth Financial Advisory's GOSS Position: Q4 2022 in Review

Toth Financial Advisory sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 100 shares — an estimated $1K sold.

Toth Financial Advisory first reported a position in GOSS in Q3 2019 and held it in 7 quarters. The position peaked at $2K in Q4 2019. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Toth Financial Advisory reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Toth Financial Advisory sold 100 Gossamer Bio shares in Q4 2022, an estimated $1K.
  • Toth Financial Advisory first reported a position in Gossamer Bio in Q3 2019 and held it in 7 quarters.
  • Toth Financial Advisory's Gossamer Bio position peaked at $2K in Q4 2019.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Toth Financial Advisory's 13F filing for Q4 2022, filed 24 Jan 2023.